Mizuho Medy Co.,Ltd. (4595.T)
JPY 1503.0
(-0.27%)
JPY 1503.0
(-0.27%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 18.94 Billion JPY | -0.8% |
| 2022 | 19.1 Billion JPY | 56.66% |
| 2021 | 12.19 Billion JPY | 101.48% |
| 2020 | 6.05 Billion JPY | -4.94% |
| 2019 | 6.36 Billion JPY | 14.04% |
| 2018 | 5.58 Billion JPY | 27.53% |
| 2017 | 4.37 Billion JPY | 8.31% |
| 2016 | 4.04 Billion JPY | 15.8% |
| 2015 | 3.49 Billion JPY | 8.48% |
| 2014 | 3.21 Billion JPY | 17.26% |
| 2013 | 2.74 Billion JPY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 18.66 Billion JPY | 0.72% |
| 2024 Q1 | 18.53 Billion JPY | -2.21% |
| 2023 Q2 | 16.55 Billion JPY | 0.67% |
| 2023 Q3 | 17.72 Billion JPY | 7.04% |
| 2023 FY | 18.94 Billion JPY | -0.8% |
| 2023 Q4 | 18.94 Billion JPY | 6.9% |
| 2023 Q1 | 16.44 Billion JPY | -13.89% |
| 2022 Q3 | 16.48 Billion JPY | 22.04% |
| 2022 Q1 | 12.18 Billion JPY | -0.06% |
| 2022 FY | 19.1 Billion JPY | 56.66% |
| 2022 Q2 | 13.5 Billion JPY | 10.86% |
| 2022 Q4 | 19.1 Billion JPY | 15.86% |
| 2021 Q2 | 9.78 Billion JPY | 32.77% |
| 2021 Q4 | 12.19 Billion JPY | 9.27% |
| 2021 FY | 12.19 Billion JPY | 101.48% |
| 2021 Q1 | 7.37 Billion JPY | 21.8% |
| 2021 Q3 | 11.15 Billion JPY | 14.03% |
| 2020 Q1 | 5.65 Billion JPY | -11.13% |
| 2020 Q3 | 5.18 Billion JPY | -1.78% |
| 2020 FY | 6.05 Billion JPY | -4.94% |
| 2020 Q4 | 6.05 Billion JPY | 16.79% |
| 2020 Q2 | 5.27 Billion JPY | -6.75% |
| 2019 Q3 | 5.63 Billion JPY | 4.1% |
| 2019 FY | 6.36 Billion JPY | 14.04% |
| 2019 Q2 | 5.41 Billion JPY | 1.2% |
| 2019 Q1 | 5.34 Billion JPY | -4.18% |
| 2019 Q4 | 6.36 Billion JPY | 12.96% |
| 2018 Q4 | 5.58 Billion JPY | 24.44% |
| 2018 Q2 | 4.43 Billion JPY | -3.24% |
| 2018 Q3 | 4.48 Billion JPY | 1.06% |
| 2018 Q1 | 4.58 Billion JPY | 4.8% |
| 2018 FY | 5.58 Billion JPY | 27.53% |
| 2017 FY | 4.37 Billion JPY | 8.31% |
| 2017 Q2 | 3.52 Billion JPY | -5.09% |
| 2017 Q3 | 3.56 Billion JPY | 1.37% |
| 2017 Q4 | 4.37 Billion JPY | 22.66% |
| 2017 Q1 | 3.7 Billion JPY | -8.22% |
| 2016 Q1 | 3.47 Billion JPY | -0.53% |
| 2016 Q4 | 4.04 Billion JPY | 35.78% |
| 2016 Q3 | 2.97 Billion JPY | -0.9% |
| 2016 Q2 | 3 Billion JPY | -13.48% |
| 2016 FY | 4.04 Billion JPY | 15.8% |
| 2015 Q4 | 3.49 Billion JPY | 0.0% |
| 2015 FY | 3.49 Billion JPY | 8.48% |
| 2014 FY | 3.21 Billion JPY | 17.26% |
| 2013 FY | 2.74 Billion JPY | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 36.57 Billion JPY | 48.19% |
| Takeda Pharmaceutical Company Limited | 15108.79 Billion JPY | 99.875% |
| Sumitomo Pharma Co., Ltd. | 907.5 Billion JPY | 97.912% |
| Shionogi & Co., Ltd. | 1416.91 Billion JPY | 98.663% |
| Wakamoto Pharmaceutical Co.,Ltd. | 15.42 Billion JPY | -22.873% |
| Nippon Shinyaku Co., Ltd. | 263.4 Billion JPY | 92.806% |
| Kaken Pharmaceutical Co., Ltd. | 171.62 Billion JPY | 88.959% |
| Eisai Co., Ltd. | 1393.79 Billion JPY | 98.641% |
| Morishita Jintan Co., Ltd. | 17.18 Billion JPY | -10.274% |
| Hisamitsu Pharmaceutical Co., Inc. | 328.77 Billion JPY | 94.237% |
| Mochida Pharmaceutical Co., Ltd. | 158.8 Billion JPY | 88.068% |
| Fuso Pharmaceutical Industries,Ltd. | 76.46 Billion JPY | 75.218% |
| Nippon Chemiphar Co., Ltd. | 49.54 Billion JPY | 61.758% |
| Tsumura & Co. | 428.25 Billion JPY | 95.575% |
| Kissei Pharmaceutical Co., Ltd. | 260.92 Billion JPY | 92.738% |
| Torii Pharmaceutical Co., Ltd. | 133.43 Billion JPY | 85.799% |
| Towa Pharmaceutical Co., Ltd. | 430.65 Billion JPY | 95.6% |
| Fuji Pharma Co., Ltd. | 85.33 Billion JPY | 77.795% |
| Zeria Pharmaceutical Co., Ltd. | 150.53 Billion JPY | 87.413% |
| KYORIN Holdings, Inc. | 177.67 Billion JPY | 89.336% |
| Taiko Pharmaceutical Co.,Ltd. | 15.04 Billion JPY | -25.936% |
| Daito Pharmaceutical Co.,Ltd. | 77.7 Billion JPY | 75.616% |
| SymBio Pharmaceuticals Limited | 15.35 Billion JPY | -23.425% |
| MedRx Co., Ltd | 2.05 Billion JPY | -823.408% |
| Solasia Pharma K.K. | 2.55 Billion JPY | -643.072% |
| Modalis Therapeutics Corporation | 2.02 Billion JPY | -835.293% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 93.31 Billion JPY | 79.694% |
| Sawai Group Holdings Co., Ltd. | 382.02 Billion JPY | 95.04% |
| Cyfuse Biomedical K.K. | 4.21 Billion JPY | -349.565% |
| Toho Holdings Co., Ltd. | 773.42 Billion JPY | 97.55% |
| Koa Shoji Holdings Co.,Ltd. | 32 Billion JPY | 40.794% |